Clinical Trial Update: Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating a four-drug regimen (pentostatin, cyclophosphamide, rituximab, mitoxantrone) in patients with chronic lymphocytic leukemia and other …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Low-grade B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Mitoxantrone (mitoxantrone)
• Pentostatin (pentostatin)
• Rituximab (rituximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-05-12